Viewing Study NCT01579994


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-04-08 @ 1:59 PM
Study NCT ID: NCT01579994
Status: COMPLETED
Last Update Posted: 2020-12-30
First Post: 2012-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adenocarcinoma View
None Lung View
None Metastatic View
None Crizotinib View
None Ganetespib View
None STA-9090 View
None ALK Positive Lung Cancers View
None 12-015 View